A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.
- Status
- TERMINATED
- Phase
- PHASE2
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors
- Status
- TERMINATED
- Phase
- PHASE1
Ruxolitinib for Chuvash Polycythemia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A